BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Emtricitabine

A deoxycytidine analog and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B viruses. It is used to treat HIV INFECTIONS.

292+ PubMed studies analyzed · 54 RCTs · Evidence Score: 49.6

Research Domains

Emtricitabine has been studied across 9 research domains including 🫘 Kidney, 🧠 Focus & Attention, 🔬 Oncology, 🫁 Liver & Detox, 😴 Sleep. The primary research focus is 🫘 Kidney with 6% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Emtricitabine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

etravirine
3 shared targets
Abacavir
3 shared targets
Lamivudine
3 shared targets
mk
2 shared targets
cefuroxime
2 shared targets
Cefmetazole
2 shared targets
Cephradine
2 shared targets
Delavirdine
3 shared targets
Cefoxitin
2 shared targets
Cefamandole
2 shared targets
Loading evidence profile...

This evidence profile for Emtricitabine is generated deterministically from 292 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.